208 related articles for article (PubMed ID: 38218922)
21. Inadequate fine-tuning of protein synthesis and failure of amino acid homeostasis following inhibition of the ATPase VCP/p97.
Parzych K; Chinn TM; Chen Z; Loaiza S; Porsch F; Valbuena GN; Kleijnen MF; Karadimitris A; Gentleman E; Keun HC; Auner HW
Cell Death Dis; 2015 Dec; 6(12):e2031. PubMed ID: 26720340
[TBL] [Abstract][Full Text] [Related]
22. Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells.
Wójcik C; Rowicka M; Kudlicki A; Nowis D; McConnell E; Kujawa M; DeMartino GN
Mol Biol Cell; 2006 Nov; 17(11):4606-18. PubMed ID: 16914519
[TBL] [Abstract][Full Text] [Related]
23. The coordinated action of VCP/p97 and GCN2 regulates cancer cell metabolism and proteostasis during nutrient limitation.
Parzych K; Saavedra-García P; Valbuena GN; Al-Sadah HA; Robinson ME; Penfold L; Kuzeva DM; Ruiz-Tellez A; Loaiza S; Holzmann V; Caputo V; Johnson DC; Kaiser MF; Karadimitris A; Lam EW; Chevet E; Feldhahn N; Keun HC; Auner HW
Oncogene; 2019 Apr; 38(17):3216-3231. PubMed ID: 30626938
[TBL] [Abstract][Full Text] [Related]
24. Pro178 and Pro183 of selenoprotein S are essential residues for interaction with p97(VCP) during endoplasmic reticulum-associated degradation.
Lee JH; Kwon JH; Jeon YH; Ko KY; Lee SR; Kim IY
J Biol Chem; 2014 May; 289(20):13758-68. PubMed ID: 24700463
[TBL] [Abstract][Full Text] [Related]
25. The immunoexpression of valosin-containing protein and small VCP-interacting protein in rat ovaries.
Kartal B; Alimoğulları E; Çaylı S
Anat Histol Embryol; 2023 Jul; 52(4):546-551. PubMed ID: 36843060
[TBL] [Abstract][Full Text] [Related]
26. Identification of SVIP as an endogenous inhibitor of endoplasmic reticulum-associated degradation.
Ballar P; Zhong Y; Nagahama M; Tagaya M; Shen Y; Fang S
J Biol Chem; 2007 Nov; 282(47):33908-14. PubMed ID: 17872946
[TBL] [Abstract][Full Text] [Related]
27. AAA ATPase p97/VCP: cellular functions, disease and therapeutic potential.
Vij N
J Cell Mol Med; 2008 Dec; 12(6A):2511-8. PubMed ID: 18798739
[TBL] [Abstract][Full Text] [Related]
28. The valosin-containing protein (VCP) is a target of Akt signaling required for cell survival.
Vandermoere F; El Yazidi-Belkoura I; Slomianny C; Demont Y; Bidaux G; Adriaenssens E; Lemoine J; Hondermarck H
J Biol Chem; 2006 May; 281(20):14307-13. PubMed ID: 16551632
[TBL] [Abstract][Full Text] [Related]
29. UV-induced proteolysis of RNA polymerase II is mediated by VCP/p97 segregase and timely orchestration by Cockayne syndrome B protein.
He J; Zhu Q; Wani G; Wani AA
Oncotarget; 2017 Feb; 8(7):11004-11019. PubMed ID: 28036256
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of p97/VCP function leads to defective autophagosome maturation, cell cycle arrest and apoptosis in mouse Sertoli cells.
Cayli S; Sahin C; Sanci TO; Nakkas H
Theriogenology; 2020 Dec; 158():196-206. PubMed ID: 32966945
[TBL] [Abstract][Full Text] [Related]
31. The differentiation/retrodifferentiation program of human U937 leukemia cells is accompanied by changes of VCP/p97.
Bertram C; von Neuhoff N; Skawran B; Steinemann D; Schlegelberger B; Hass R
BMC Cell Biol; 2008 Feb; 9():12. PubMed ID: 18279508
[TBL] [Abstract][Full Text] [Related]
32. VCP/p97 AAA-ATPase does not interact with the endogenous wild-type cystic fibrosis transmembrane conductance regulator.
Goldstein RF; Niraj A; Sanderson TP; Wilson LS; Rab A; Kim H; Bebok Z; Collawn JF
Am J Respir Cell Mol Biol; 2007 Jun; 36(6):706-14. PubMed ID: 17272822
[TBL] [Abstract][Full Text] [Related]
33. The VCP/p97 system at a glance: connecting cellular function to disease pathogenesis.
Meyer H; Weihl CC
J Cell Sci; 2014 Sep; 127(Pt 18):3877-83. PubMed ID: 25146396
[TBL] [Abstract][Full Text] [Related]
34. Valosin-containing protein VCP/p97 is essential for the intracellular development of Leishmania and its survival under heat stress.
Guedes Aguiar B; Padmanabhan PK; Dumas C; Papadopoulou B
Cell Microbiol; 2018 Oct; 20(10):e12867. PubMed ID: 29895095
[TBL] [Abstract][Full Text] [Related]
35. Valosin containing protein (VCP): initiator, modifier, and potential drug target for neurodegenerative diseases.
Chu S; Xie X; Payan C; Stochaj U
Mol Neurodegener; 2023 Aug; 18(1):52. PubMed ID: 37545006
[TBL] [Abstract][Full Text] [Related]
36. Structural basis for ovarian tumor domain-containing protein 1 (OTU1) binding to p97/valosin-containing protein (VCP).
Kim SJ; Cho J; Song EJ; Kim SJ; Kim HM; Lee KE; Suh SW; Kim EE
J Biol Chem; 2014 May; 289(18):12264-74. PubMed ID: 24610782
[TBL] [Abstract][Full Text] [Related]
37. Temporal proteomics reveal specific cell cycle oncoprotein downregulation by p97/VCP inhibition.
Wang F; Li S; Houerbi N; Chou TF
Cell Chem Biol; 2022 Mar; 29(3):517-529.e5. PubMed ID: 34847375
[TBL] [Abstract][Full Text] [Related]
38. TMUB1 is an endoplasmic reticulum-resident escortase that promotes the p97-mediated extraction of membrane proteins for degradation.
Wang L; Li J; Wang Q; Ge MX; Ji J; Liu D; Wang Z; Cao Y; Zhang Y; Zhang ZR
Mol Cell; 2022 Sep; 82(18):3453-3467.e14. PubMed ID: 35961308
[TBL] [Abstract][Full Text] [Related]
39. Regulation of VCP/p97 demonstrates the critical balance between cell death and epithelial-mesenchymal transition (EMT) downstream of ER stress.
Shah PP; Beverly LJ
Oncotarget; 2015 Jul; 6(19):17725-37. PubMed ID: 25970786
[TBL] [Abstract][Full Text] [Related]
40. Structural and mechanistic insights into the arginine/lysine-rich peptide motifs that interact with P97/VCP.
Liu S; Fu QS; Zhao J; Hu HY
Biochim Biophys Acta; 2013 Dec; 1834(12):2672-8. PubMed ID: 24100225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
